Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caging cancer.

Lajos P Balogh1

  • 1AA Nanomedicine & Nanotechnology, Amherst, NY, USA.

Nanomedicine : Nanotechnology, Biology, and Medicine
|March 4, 2015
PubMed
Summary

Personalized cancer treatment faces challenges due to patient variability. Nanomedicines like gadolinium fullerenol cages offer a promising approach, simultaneously targeting multiple cancer features for improved efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beware of phosphate: evidence of specific dendrimer-phosphate interactions.

Physical chemistry chemical physics : PCCP·2017
Same author

Diverse Applications of Nanomedicine.

ACS nano·2017
Same author

The 4th Annual Meeting of the American Society for Nanomedicine.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2014
Same author

Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition.

Pharmaceutical research·2012
Same author

In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges.

Nanotoxicology·2012
Same author

The nanoscopic range and the effect of architecture on nanoproperties.

Nanomedicine : nanotechnology, biology, and medicine·2010

Area of Science:

  • Oncology
  • Nanomedicine
  • Materials Science

Background:

  • Cancer treatment is complex due to individual patient differences, including genetics and tumor characteristics.
  • Current chemotherapy often lacks specificity, requiring combination regimens.
  • Nanomedicines offer potential for multi-targeted therapies.

Purpose of the Study:

  • To summarize challenges in cancer treatment.
  • To highlight the potential of nanomedicines for personalized cancer therapy.
  • To introduce gadolinium fullerenol cage molecules as a novel therapeutic agent.

Main Methods:

  • Review of existing literature on cancer treatment challenges.
  • Analysis of nanomedicine potential in targeting multiple cancer pathways.
  • Presentation of experimental data on gadolinium fullerenol cage molecules (Gd@C82(OH)22).

Main Results:

  • Gadolinium fullerenol cage molecules demonstrate low toxicity.
  • Gd@C82(OH)22 influences multiple biological features simultaneously.
  • The molecule exhibits tumoristatic properties and efficacy against triple-negative breast cancer cells.

Conclusions:

  • Understanding the relationship between physicochemical properties and biological effects is crucial.
  • Gadolinium fullerenol cage molecules represent a potential new class of anticancer drugs.
  • Nanomedicine offers a promising avenue for developing customized cancer therapies.
Keywords:
Cancer patientsGd@C(82)(OH)(22)Individual differencesMetallofullerenolTreatment modalitiesTumoristatic

Related Experiment Videos